Adding Curcuminoids to Docetaxel Promising in Prostate Cancer

Jelson

while the article is about use in prostate cancer, it does mention clinical trials of curcuminoids/docetaxel for breast cancer: “We wanted to potentiate docetaxel by curcuminoids in CRPC first line.” In a previous phase I trial he and colleagues evaluated the safety and tolerability of the addition of curcuminoids to docetaxel for treatment of advanced breast cancers."

http://www.cancernetwork.com/conference-reports/asco2013/prostate-cancer/content/article/10165/2145565